The healthcare industry is in a radical state of transformation, and biopharma players need to adapt to a systems-oriented approach to protect revenues, grow market share, and obtain regulatory approval for new treatments.

Perspectives on a systems oriented approach
Featured Video

Systems-Oriented Drug Development
Patrick Jordan explains why a systems-oriented approach must include healthcare stakeholder feedback into clinical development. This is the player to use for single videos on ...

Did you know...

Only 16-19% of biopharma, payer and provider executives say they were mostly aligned with other stakeholders, while one-fourth said they are not very or not at all aligned.
More than 70% of biopharma, payer and provider executives believe transparency around data sources and information-sharing across stakeholders is very important or critically important to the success of an interoperable healthcare system.
At least 3 out of 4 biopharma, payer and provider executives believe it is very important or extremely important for data sources collected by different stakeholders to be linked together to better inform decisions.

Quintiles Blog

Fresh ideas and insights from our experts around the globe


Quintiles Expert

Senior Vice President, Consulting at Quintiles

Recent thinking: HTA and CER: What US Payers Can Learn From Their UK Peers

Chief Administration Officer, Encore, A Quintiles Company

Recent thinking: Biopharmas Specialization Trends

Senior Vice President and Global Head, Clinical Design & Reporting Services

Recent thinking: Data Integration and Partnerships